about
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision End...
Read More
28.00
0.05
(0.18%)
728.5K
XNAS Volume
XNAS 13 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for MBX Biosciences Inc is on 17 Mar 2026 for the purpose of MBX Biosciences Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
MBX Biosciences Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..